Moderna stock rises on flu vaccine data and FDA approvals, while healthcare stocks remain under pressure amid political ...

In this week’s edition of InnovationRx, we look at Moderna’s use of quantum computers, a new top drug regulator at the FDA, ...

Artworks of various mediums by 46 Chinese and Italian artists are now on show at the Galleria Nazionale d'Arte Moderna e ...

Moderna said on Friday it is cancelling plans to build a messenger RNA manufacturing plant in Japan due to "changes in the ...

A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector.

Moderna, already in cash-saving mode amid uncertain vaccine dynamics, is backing off from its plans to construct an mRNA drug ...

Moderna (MRNA) stock in focus as the company cancels plans for an mRNA manufacturing plant in Japan amid a challenging ...

The two companies collaborated on research showing quantum computing could greatly aid the design of mRNA-based medicines and ...

The chief engine of the U.S. economy lies in intangible investments, such as research and development, software, ...

Mary Talley Bowden, MD, founder of Americans for Health Freedom, an advocacy group that has lobbied against mRNA shots, ...

In the most recent trading session, Moderna (MRNA) closed at $31.25, indicating a -2.95% shift from the previous trading day.

Most people think of vaccines as being "preventive," and taken to "prevent or lessen the impact of certain infectious ...